Chinese plant extract calls for global standard

May 3
08:55

2012

David Yvon

David Yvon

  • Share this article on Facebook
  • Share this article on Twitter
  • Share this article on Linkedin

Chinese medicines are frustrated in EU, but plant extracts have broad prospects. Recently, the first standardized international symposium of traditional Chinese medicine and herbal extract was held in Wuhan, China.

mediaimage

Participants from all walks of life called for the development of internationally harmonized standards for Chinese plant extracts to meet international market demand as soon as possible. Plant extracts as the main raw material of modern herbal preparations,Chinese plant extract calls for global standard Articles it integrates with modern pharmaceutical technology and becomes a core product in the natural medicine and health products market, a huge market space of natural medicine and health products plant extracts become the hottest product on the international market. China Chinese medicine due to the problem of identity is difficult to be opened to the markets in developed countries, plant extracts because of their return to nature and green consumer is became fashionable, and highly respected in the Western developed countries, the internationalization of Chinese medicine has opened up new paths.

Chinese plant extracts industry due to the guidance of the theory of traditional Chinese medicine, has unique advantages for development. At present, the Chinese plant extracts has formed a certain scale. The mainstream pharmaceutical raw materials suppliers is competitive in the production equipment and technology comparing to the world's major producing countries Germany, Italy and Spain.

Plant extracts is the main force of Chinese merchandise exports in the field of China's exports last year raised to $ 801.5 billion, accounting for 41.92 percent of total merchandise exports in the traditional Chinese medicine. The EU's seven-year transition period after the end of April 30 last year, due to Chinese proprietary Chinese medicines is not successfully registered proprietary Chinese medicines will say goodbye to the EU. The industry believes that the EU market as the herbal market of proprietary Chinese medicines frustrated or will create an opportunity for plant extracts.

At present, the items of plant extracts of the Chinese production has reached hundreds of species, including the formation of large-scale production and export of plant extracts of Ginkgo biloba extract, green tea extract, ginseng extract. These products have a larger market share in Western countries. Plant extracts industry in China in recent years has made considerable progress, industry concentration has improved significantly, but industry enterprises are still small-scale, product innovation, international market development capability is weak.

As an emerging industry, most of China's plant extracts lack of uniform standards. Chinese manufacturers have been guided by customer standards. They are doing the production according to customer requirements. Although they have simple operation, the drawbacks are obvious. Once the customers are doubt about the quality of products, manufacturers will be controlled by others and many companies suffer losses. A number of experts called for the country to have internationally harmonized standards as soon as possible. And with the use of advanced inspection, testing techniques and methods according to international standards, China should establish a standardized system for plant extracts. Source:http://www.cospcn.com